Broth microdilution protocol for determining antimicrobial susceptibility of Legionella pneumophila to clinically relevant antimicrobials.

Autor: Sewell M; Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK., Farley C; Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK., Portal EAR; Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK; Ineos Oxford Institute for Antimicrobial Research (IOI), Department of Biology, University of Oxford, UK., Lindsay D; Scottish Microbiology Reference Laboratories, Glasgow Royal Infirmary, Glasgow, UK., Ricci ML; National Institute for Health, Rome, Italy., Jarraud S; Centre National de Reference des Legionelles, University de Lyon, France., Scaturro M; National Institute for Health, Rome, Italy., Descours G; Centre National de Reference des Legionelles, University de Lyon, France., Krøvel AV; National Reference Laboratory for Legionella, Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway., Barton R; Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK., Boostom I; Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK., Ure R; Scottish Microbiology Reference Laboratories, Glasgow Royal Infirmary, Glasgow, UK., Kese D; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Gaia V; Department of laboratory medicine, Reference Centre for Legionella, Switzerland., Golob M; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Paukner S; Nabriva Therapeutics GmbH, Vienna, Austria., Ginevra C; Centre National de Reference des Legionelles, University de Lyon, France., Afshar B; UK Health Security Agency, Bacteriology Reference Department, London, UK., Nadarajah S; UK Health Security Agency, Bacteriology Reference Department, London, UK., Wybo I; Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Department of Microbiology and infection control, National Reference Centre for Legionella pneumophila, Brussels, Belgium., Michel C; Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Department of Microbiology and infection control, National Reference Centre for Legionella pneumophila, Brussels, Belgium., Echahdi F; Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Department of Microbiology and infection control, National Reference Centre for Legionella pneumophila, Brussels, Belgium., González-Rubio JM; Legionella Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda, Spain., González-Camacho F; Legionella Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda, Spain., Mentasti M; Public Health Wales Microbiology, University Hospital of Wales, Cardiff, UK., Flountzi AS; Central Public Health Laboratory, Hellenic National Public Health Organization, Vari-Athens, Attica, Greece., Petzold M; Institute of Medical Microbiology and Virology, University Hospital Carl Gustav Carus Dresden Dresden University of Technology, Dresden, Germany., Moran-Gilad J; Department of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel., Uldum S; Department of Bacteria, Parasites & Fungi, Statens Serum Institut, Denmark., Winchell J; Centres for Disease Control and Prevention, National Centre for Immunization and Respiratory Diseases, Atlanta, GA, USA., Wooton M; Public Health Wales Microbiology, University Hospital of Wales, Cardiff, UK; British Society of Antimicrobial Chemotherapy representative for EUCAST steering committee, 53 Regent Place, Birmingham, UK., Bernard K; Special Bacteriology Unit, National Microbiology Laboratory-PHAC, Winnipeg, Canada., Jones LC; Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK., Chalker VJ; Deputy Chief Scientific Officer for the UK, Wellington house, 133-155 Waterloo rd., London, UK., Spiller OB; Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, UK; UK Health Security Agency, Bacteriology Reference Department, London, UK. Electronic address: SpillerB@cardiff.ac.uk.

Publikováno v: Journal of microbiological methods [J Microbiol Methods] 2024 Dec 18; Vol. 228, pp. 107071. Date of Electronic Publication: 2024 Dec 18.

Characterisation of Legionella Clinical Isolates in Spain from 2012 to 2022.

Autor: González-Rubio JM; Legionella Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain., Cascajero A; Legionella Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain., Baladrón B; Legionella Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain., González-Camacho F; Legionella Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain.

Publikováno v: Microorganisms [Microorganisms] 2024 Jun 21; Vol. 12 (7). Date of Electronic Publication: 2024 Jun 21.

Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study.

Autor: Sempere J; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Llamosí M; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain., López Ruiz B; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain., Del Río I; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain., Pérez-García C; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain., Lago D; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain., Gimeno M; Scientific Department, Meiji Pharma Spain, Madrid, Spain., Coronel P; Scientific Department, Meiji Pharma Spain, Madrid, Spain., González-Camacho F; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain., Domenech M; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain; Department of Genetics, Physiology and Microbiology, University Complutense Madrid, Madrid, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain. Electronic address: miridome@ucm.es., Yuste J; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain. Electronic address: jyuste@isciii.es.

Publikováno v: The Lancet. Microbe [Lancet Microbe] 2022 Oct; Vol. 3 (10), pp. e744-e752. Date of Electronic Publication: 2022 Aug 03.

Minilungs from Human Embryonic Stem Cells to Study the Interaction of Streptococcus pneumoniae with the Respiratory Tract.

Autor: Sempere J; Biotechnology of Stem Cells and Organoids, Chronic Diseases Program, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain.; Spanish Pneumococcal Reference Laboratory, Centro Nacional de Microbiología, and CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain., Rossi SA; Biotechnology of Stem Cells and Organoids, Chronic Diseases Program, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain.; Department of Microbiology, Biomedical Sciences Institute, University of São Paulo (USP), São Paulo, Brazil.; Mycology Reference Laboratory, Centro Nacional de Microbiología and CIBER of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain., Chamorro-Herrero I; Biotechnology of Stem Cells and Organoids, Chronic Diseases Program, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain., González-Camacho F; Spanish Pneumococcal Reference Laboratory, Centro Nacional de Microbiología, and CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain., de Lucas MP; Cellular Biology Unit, Chronic Diseases Program and CIBER of Cancer (CIBERONC), Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain., Rojas-Cabañeros JM; Cellular Biology Unit, Chronic Diseases Program and CIBER of Cancer (CIBERONC), Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain., Taborda CP; Department of Microbiology, Biomedical Sciences Institute, University of São Paulo (USP), São Paulo, Brazil., Zaragoza Ó; Mycology Reference Laboratory, Centro Nacional de Microbiología and CIBER of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain., Yuste J; Spanish Pneumococcal Reference Laboratory, Centro Nacional de Microbiología, and CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain., Zambrano A; Biotechnology of Stem Cells and Organoids, Chronic Diseases Program, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain.

Publikováno v: Microbiology spectrum [Microbiol Spectr] 2022 Jun 29; Vol. 10 (3), pp. e0045322. Date of Electronic Publication: 2022 Jun 13.

A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004-20 in Spain.

Autor: Sempere J; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid 28220, Spain., González-Camacho F; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid 28220, Spain., Domenech M; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid 28220, Spain.; Department of Genetics, Physiology, and Microbiology, Faculty of Biology, University Complutense of Madrid, Madrid 28040, Spain., Llamosí M; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid 28220, Spain., Del Río I; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid 28220, Spain., López-Ruiz B; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid 28220, Spain., Gimeno M; Scientific Department, Meiji Pharma Spain, Madrid 28802, Spain., Coronel P; Scientific Department, Meiji Pharma Spain, Madrid 28802, Spain., Yuste J; Spanish Pneumococcal Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Madrid 28220, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Madrid 28029, Spain.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Mar 31; Vol. 77 (4), pp. 1045-1051.